Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2556211

CCCCCCCCCCCCCCCCCC(=O)C(CN(C)C)C(=O)CCCCCCCCCCCCCCCCC.Cl

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 2/20 0.43
HDAC11 known ✓ Q96DB2 1/20 0.43
CES2 O00748 4/20 0.52
CES1 P23141 3/20 0.45
MEN1 O00255 1/20 0.44
FAAH O00519 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
GPR84 Q9NQS5 2/20 0.43
PPARD Q03181 2/20 0.43
PPARA Q07869 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28877 1.00 CES2 (0.52) CES2CES1MEN1FAAHMAPK1
SCHEMBL540829 0.98 CES2 (0.53) CES2CES1MEN1FAAHMAPK1
SCHEMBL5533299 0.98 CES2 (0.53) CES2CES1MEN1FAAHMAPK1
Hydrochloric Acid SCHEMBL6565482 0.90 TERT (0.53) MEN1FAAHKMT2APPARGPPARD
SCHEMBL23491293 0.88 TERT (0.54) MEN1FAAHKMT2APPARGPPARD
SCHEMBL532716 0.88 TERT (0.54) MEN1FAAHKMT2APPARGPPARD
SCHEMBL28532295 0.85 CES2 (0.42) CES2MEN1FAAHMAPK1KMT2A
Hydrochloric Acid SCHEMBL16322648 0.83 CES2 (0.50) CES2CES1MEN1FAAHMAPK1
Sulfuric Acid SCHEMBL28836767 0.83 TERT (0.49) MEN1FAAHKMT2APPARGPPARD
Sulfuric Acid SCHEMBL28836761 0.83 TERT (0.49) MEN1FAAHKMT2APPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114599334-A Stable low pH personal care compositions and methods therefor 高露洁-棕榄公司 2022-06-07 CN claimed
EP-2413879-B1 CAPILLARY COMPOSITION FOR TREATING HAIR L'ORÉAL (FR) 2017-08-16 EP claimed
US-20120103358-A1 CAPILLARY COMPOSITION FOR TREATING HAIR L'OREAL (FR) 2012-05-03 US claimed
US-20020012650-A1 Hair cures and hair rinses, comprising quaternary ammonium compounds and having pearly luster effect CLARIANT GMBH 2002-01-31 US claimed
CN-115697290-A Cosmetic compositions with enhanced color stability against retinoic acid precursors 联合利华知识产权控股有限公司 2023-02-03 CN disclosed
CN-114599334-A Stable low pH personal care compositions and methods therefor 高露洁-棕榄公司 2022-06-07 CN disclosed
CN-113677321-A Composition comprising a specific hyperbranched copolymer and 1, 3-propanediol and/or N-hydroxyoctanoylamide 帝斯曼知识产权资产管理有限公司 2021-11-19 CN disclosed
CN-113164345-A Cosmetic composition comprising a specific hyperbranched copolymer and an oil 帝斯曼知识产权资产管理有限公司 2021-07-23 CN disclosed
CN-113164795-A Cosmetic composition comprising a dispersion of a specific hyperbranched copolymer and an acrylic polymer 帝斯曼知识产权资产管理有限公司 2021-07-23 CN disclosed
CN-113164373-A Cosmetic composition comprising a specific hyperbranched copolymer and an organic UV filter 帝斯曼知识产权资产管理有限公司 2021-07-23 CN disclosed
CN-113164796-A Cosmetic composition comprising a specific hyperbranched copolymer and an anionic emulsifier 帝斯曼知识产权资产管理有限公司 2021-07-23 CN disclosed
CN-113164359-A Cosmetic composition comprising a specific hyperbranched copolymer and a nonionic emulsifier which is an ether or ester of a (poly) ethylene oxide 帝斯曼知识产权资产管理有限公司 2021-07-23 CN disclosed
CN-106309149-B Emulsions comprising cationic emulsifiers based on methyldiisopropanolamine Quaternary ammonium Compounds 赢创运营有限公司 2021-06-15 CN disclosed
CN-105434183-B Formulations comprising esterquat compounds based on isopropanolamine and tetrahydroxypropylethylenediamine 赢创运营有限公司 2021-01-01 CN disclosed
WO-2012139937-A2 CATIONIC COSMETIC COMPOSITION UNILEVER PLC (GB) 2012-10-18 WO disclosed
US-20120259011-A1 PERSONAL CARE COMPOSITIONS WITH CATIONIC DIESTERS AND DIHYDROXYPROPYL QUATERNARY AMMONIUM SALTS CONOPCO, INC., D/B/A UNILEVER (US) 2012-10-11 US disclosed
US-20120259010-A1 CATIONIC COSMETIC COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2012-10-11 US disclosed
WO-2011128309-A1 COMPOSITION AND TREATMENT PROCESS USING PUMICE PARTICLES L'OREAL (FR) 2011-10-20 WO disclosed
US-20080305056-A1 STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS EVONIK GOLDSCHMIDT GMBH (DE) 2008-12-11 US disclosed
US-20020012650-A1 Hair cures and hair rinses, comprising quaternary ammonium compounds and having pearly luster effect CLARIANT GMBH 2002-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120259010-A1 CATIONIC COSMETIC COMPOSITION KCNN3, KCNN1, KCNN2 PPARG 1537/4885HDAC11 736/4885CES2 1110/4885
US-20080305056-A1 STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS QARS1, QPCTL, CUTA PPARG 877/4885HDAC11 1735/4885CES2 3611/4885
US-20120259011-A1 PERSONAL CARE COMPOSITIONS WITH CATIONIC DIESTERS AND DIHYDROXYPROPYL QUATERNARY AMMONIUM SALTS IL33, DLAT, CUTA PPARG 2306/4885HDAC11 1267/4885CES2 3144/4885
US-20120103358-A1 CAPILLARY COMPOSITION FOR TREATING HAIR POLE3, POLR1C, PUM1 PPARG 3241/4885HDAC11 837/4885CES2 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.